カジノ 無料 ゲーム アプリ for upcoming Biotech online pitch event

🎉カジノ 無料 ゲーム アプリ for upcoming Biotech online pitch event🎉

カジノ 無料 ゲーム アプリill be organising an online pitch event for Biotech and pharmaceutical start-ups, aiming to connect them with Japanese pharmaceutical companies and VC/CVCs.

Date and time

Date: 24 October 2024 (Thursday)

Time: 9am-12pm (UK time)

Format

- Online; 6-8 SUs will pitch to Japanese pharmaceutical companies, VC and CVCs.

- Each selected SU will pitch for 6 min followed by a 6 min Q&A session with various evaluators (which consist of Japanese VC, CVC and pharmaceutical companies).

- カジノ 無料 ゲーム アプリvaluators will select the most outstanding SUs at カジノ 無料 ゲーム アプリnd of カジノ 無料 ゲーム アプリvent.

- Additional Japanese pharmaceutical company representatives and investors will participate amongst the audience.

SU selection criteria

1. Biopharmaceutical start-ups which have new drug development pipeline (ideally in preclinical or clinical trial phase 1-2).

2. Need to meet either of the following criteria:

- Third party recommendations from first-class national research institutes, academia or VCs.

- The CEO or founder is a serial entrepreneur or was successful in the pharmaceutical industry in his/her career in the past.

Evaluators

For this pitch event, we invited five evaluators from Japanese VCs and CVCs of pharmaceutical companies who are well known in Japan's biotech sector:

- University of Tokyo IPC (VC), Mr Ohori Makoto

- Astellas Pharma (Pharmaceutical company), Mr Usuda Hiroyuki

- AN Ventures (VC), Mr Shimada Atsushi

- Global Brain (VC), Mr Takai Hiroki

- Taiho Innovations (CVC), Mr Miyakoshi Hitoshi

Benefits for SUs

- Connecting with the listed evaluators and getting feedback from them.

- Additional representatives from Japanese pharmaceutical companies will be invited (networking opportunity).

- Event report will be published on the カジノ 無料 ゲーム アプリebsite & most notable SUs will be presented.

How to apply

Please register via this application form: https://forms.office.com/r/sS9y9tyGdA

Deadline: 27 September (Friday)